Don’t Jump to Talicia for H. pylori Treatment

May 2020

Talicia will be a new combo pill for treating H. pylori.

It combines rifabutin, amoxicillin, and omeprazole in one cap.

You’ll hear Talicia has minimal resistance...rifabutin’s resistance rates are under 5%. Other antibiotics...macrolides, metronidazole, or levofloxacin...have higher resistance rates.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Infectious Diseases Discourage Inappropriate Use of Hydroxychloroquine for COVID-19
Mental Health Offer Coping Strategies to Distressed Patients or Colleagues
Diabetes Meds Be Aware of SGLT2 Inhibitor Risks
Infectious Diseases Dispel Misinformation About Meds and Supplements for COVID-19
Practice Embrace Telemedicine as a Tool to Enhance Patient Care
Insomnia Explain That Insomnia Meds Are Only Modestly Helpful
Generics Understand Nuances About Generic Prescribing and Substitution
Gastroenterology Don’t Jump to Talicia for H. pylori Treatment
Allergic Reactions Know How to Determine if Med Containers Have Latex
Infectious Diseases Know the Roles of Remdesivir and IL-6 Inhibitors for COVID-19
Practice Streamline Med Profiles for Patients in Isolation
Antibiotics Be Ready to Monitor Vancomycin With AUC/MIC Goals
Infectious Diseases Put Inpatient Hydroxychloroquine Use for COVID-19 in Perspective

Don’t Jump to Talicia for H. pylori Treatment

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents